Precision BioSciences, Inc.
DTIL
$4.71
$0.020.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 40.98% | 43.62% | 88.35% | 88.25% | 94.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.98% | 43.62% | 88.35% | 88.25% | 94.15% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 40.98% | 43.62% | 88.35% | 88.25% | 94.15% |
| SG&A Expenses | -9.69% | -20.14% | -19.22% | -17.60% | -10.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.59% | -2.08% | 5.72% | -8.13% | -14.99% |
| Operating Income | 40.18% | 60.43% | 83.14% | 50.40% | 47.73% |
| Income Before Tax | 116.85% | 123.66% | 130.31% | 75.05% | 54.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 116.85% | 123.66% | 130.31% | 75.05% | 54.91% |
| Earnings from Discontinued Operations | -- | 88.58% | 103.15% | 72.98% | -8.52% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 111.69% | 111.73% | 118.98% | 74.50% | 45.07% |
| EBIT | 40.18% | 60.43% | 83.14% | 50.40% | 47.73% |
| EBITDA | 38.36% | 64.20% | 93.91% | 53.87% | 51.34% |
| EPS Basic | 112.00% | 100.41% | 100.95% | 78.06% | 61.54% |
| Normalized Basic EPS | 117.68% | 104.50% | 95.71% | 74.60% | 66.80% |
| EPS Diluted | 111.80% | 100.26% | 100.84% | 78.06% | 61.54% |
| Normalized Diluted EPS | 117.40% | 104.18% | 95.42% | 74.60% | 66.80% |
| Average Basic Shares Outstanding | 79.78% | 53.86% | 32.21% | 23.75% | 29.93% |
| Average Diluted Shares Outstanding | 80.09% | 54.17% | 32.53% | 23.77% | 29.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
